Pentwater Capital Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Pentwater Capital Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,698,719	Closed	-$147M	–	151
2016 Q3	$147M	Buy	+3,698,719	New	+$41.3M	1.36%	18

Pentwater Capital Management's TBRA Position: Q4 2016 in Review

Pentwater Capital Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 3,698,719 shares — an estimated $147M sold.

Pentwater Capital Management first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $147M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Pentwater Capital Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Pentwater Capital Management sold 3,698,719 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $147M.
Pentwater Capital Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Pentwater Capital Management's Tobira Therapeutics, Inc. Common Stock position peaked at $147M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Pentwater Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.